Literature DB >> 20706137

Contributory role of endothelium and voltage-gated potassium channels in apocynin-induced vasorelaxations.

Wei-qing Han1, Wing Tak Wong, Xiao Yu Tian, Yu Huang, Ling-yun Wu, Ding-liang Zhu, Ping-jin Gao.   

Abstract

OBJECTIVE: Although apocynin, the nicotinamide adenine dinucleotide phosphate oxidase inhibitor improves vascular function in hypertension, its specificity has been questioned. The present study examined whether apocynin-induced vasorelaxations involve endothelium and/or K channels in vascular cells.
METHODS: Aortas from Sprague-Dawley rats were suspended in organ baths for functional studies. Changes in intracellular calcium ([Ca]i) and nitric oxide ([NO]i) in rat endothelial cells were detected by fluorescence imaging. Whole-cell voltage-gated K (Kv) currents were recorded in vascular smooth muscle cells.
RESULTS: Apocynin-induced aortic relaxations were attenuated by the absence of endothelium, endothelial nitric oxide synthase inhibitor N-nitro-L-arginine methyl ester, or nitric oxide-dependent soluble guanylate cyclase inhibitor 1H-[1,2,4] oxadiazolo [4,3-a] quinoxalin-1-one. 4-Aminopyridine (4-AP, voltage-gated potassium channels blocker) attenuated apocynin-induced relaxations, its combined treatment with 1H-[1,2,4] oxadiazolo [4,3-a] quinoxalin-1-one (ODQ) did not cause further inhibition. Apocynin increased [Ca]i and [NO]i in endothelial cells, which were abolished by 4-AP, indicating the involvement of voltage-gated potassium channels in endothelial cells. In addition, apocynin-stimulated increase in endothelial nitric oxide synthase phosphorylation at Ser depended on the presence of extracellular Ca. Notably, 4-AP also reduced apocynin-induced relaxations in the absence of endothelium and apocynin increased 4-AP-sensitive voltage-gated potassium channel currents in vascular smooth muscle cells.
CONCLUSION: This study provides novel data showing that apocynin-induced relaxations of rat aortas are mediated by 4-AP-sensitive stimulation of [Ca]i and [NO]i increases in endothelium and by activation of voltage-gated potassium channels in vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20706137     DOI: 10.1097/HJH.0b013e32833d0197

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Exercise training reverses aging-induced impairment of myogenic constriction in skeletal muscle arterioles.

Authors:  Payal Ghosh; Fredy R Mora Solis; James M Dominguez; Scott A Spier; Anthony J Donato; Michael D Delp; Judy M Muller-Delp
Journal:  J Appl Physiol (1985)       Date:  2015-01-29

2.  Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition.

Authors:  Wei-Qing Han; Lian Xu; Xiao-Feng Tang; Wen-Dong Chen; Yong-Jie Wu; Ping-Jin Gao
Journal:  J Physiol       Date:  2018-07-23       Impact factor: 5.182

3.  Non-endothelial endothelin counteracts hypoxic vasodilation in porcine large coronary arteries.

Authors:  Elise R Hedegaard; Edgaras Stankevicius; Ulf Simonsen; Ole Fröbert
Journal:  BMC Physiol       Date:  2011-05-15

4.  Ropivacaine-induced contraction is attenuated by both endothelial nitric oxide and voltage-dependent potassium channels in isolated rat aortae.

Authors:  Seong-Ho Ok; Jeong Yeol Han; Hui-Jin Sung; Seong Min Yang; Jungchul Park; Seong-Chun Kwon; Mun-Jeoung Choi; Ju-Tae Sohn
Journal:  Biomed Res Int       Date:  2013-11-20       Impact factor: 3.411

5.  mTOR contributes to endothelium-dependent vasorelaxation by promoting eNOS expression and preventing eNOS uncoupling.

Authors:  Yiying Wang; Qiannan Li; Zhiyang Zhang; Kai Peng; Dai-Min Zhang; Qianlu Yang; Anthony G Passerini; Scott I Simon; ChongXiu Sun
Journal:  Commun Biol       Date:  2022-07-22

6.  Mechanisms of improved aortic stiffness by arotinolol in spontaneously hypertensive rats.

Authors:  Wugang Zhou; Mona Hong; Ke Zhang; Dongrui Chen; Weiqing Han; Weili Shen; Dingliang Zhu; Pingjin Gao
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.